Control T-cells derived from the same donor and not equipped with the CD19 CAR did not confer any relevant reactivity against CD19high and CD19low myeloma cells (Fig. 3 and Supplementary Fig. 4). This evidence concerns the gene CD19 and plasma cell myeloma.